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a b s t r a c t
Ethnopharmacological relevance: Cassia occidentalis L. (syn. Senna occidentalis; Leguminosae) has been
used as natural medicine in rainforests and tropical regions as laxative, analgesic, febrifuge, diuretic,
hepatoprotective, vermifuge and colagogo. Herein, we performed a pre-clinical safety evaluation of
hydroalcoholic extract of Cassia occidentalis stem and leaf in male and female Wistar rats.
Materials and methods: In acute toxicity tests, four groups of rats (n=5/group/sex) were orally treated
with doses of 0.625, 1.25, 2.5 and 5.0 g/kg and general behavior, adverse effects and mortality were
recorded for up to 14 days. In subacute toxicity assays, animals received Cassia occidentalis by gavage at
the doses of 0.10, 0.50 or 2.5 g/kg/day (n=10/group/sex) for 30 days and biochemical, hematological and
morphological parameters were determined.cute toxicity
ubacute toxicity
iochemical and hematological parameters
Results: Cassia occidentalis did not produce any hazardous symptoms or death in the acute toxicity test,
showing a LD50 higher than 5g/kg. Subacute treatment with Cassia occidentalis failed to change body
weight gain, food and water consumption and hematological and biochemical proﬁles. In addition, no
changes in macroscopical and microscopical aspect of organs were observed in the animals.
Conclusions: Our results showed that acute or subacute administration of Cassia occidentalis is not toxic
in male and female Wistar rats, suggesting a safety use by humans.
 . Introduction
Cassia occidentalis L. (syn. Senna occidentalis), family Legumi-
osae, is found in many tropical areas of South America including
he Brazilian Amazon region, is widely used as a medicinal plant
n several countries and is popularly known as Fedegoso or Man-
erioba. In traditional medicine, various parts of this plant (seeds,
oots, leaves and stems) have been widely used as a laxative, anal-
esic, febrifuge, diuretic, hepatoprotective, vermifuge and colagogo
s well as for the treatment of tuberculosis, gonorrhea, dysmen-
rrhea, anemia, ﬂu and liver and urinary tract diseases (Coimbra,
994; Di Stasi and Hiruma-Lima, 2002). In Brazil, hydroalcoholic
xtract of Cassia occidentalis stem and leaf has been marketed by
harmaceutical Laboratory (LAPERLI) with commercial name of
assia Virgínica® and has been indicated for the treatment of ﬂu,
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fever, erysipelas, febrifuge and as analgesic, hepatoprotective and
diuretic.
Toxicological studies have shown potent toxic effects of Cassia
occidentalis seeds in animals (Tasaka et al., 2000). Signs of Cas-
sia occidentalis seeds poisoning in general include independently
of animal species: ataxia, muscle weakness, stubbing, and body
weight loss, eventually leading to death. Skeletal muscle degener-
ation is the predominant lesion found in the majority of animals
intoxicated with Cassia occidentalis (O’Hara et al., 1969; Calore
et al., 1997; Haraguchi et al., 2003). Mechanism of Cassia occiden-
talis toxicity has been described as being due to impairment of
mitochondrial function, including swelling, loss of mitochondrial
matrix, fragmented mitochondrial cristae and glycogen depletion
(O’HaraandPierce, 1974;Caloreet al., 1997).Haraguchi et al. (1996)
identiﬁeddianthrone, anantharquinone-derived compound inCas-
sia occidentalis seeds anddemonstrated that these substances could
cause the characteristic mitochondrial myopathy produced by this
plant.
Although well characterized the toxic effects of the seeds of
Open access under the Elsevier OA license.Cassia occidentalis, the toxicity of other parts of the plant is not
well determined. Therefore, our research group has investigated
the possible toxic effect of the stems and leaves of Cassia occi-


















































o42 M.G.B. Silva et al. / Journal of Eth
aboratorydemonstrated that the treatmentduringpregnancywith
ydroalcoholic extract of Cassia occidentalis stems and leaves pro-
uced no signiﬁcant changes in the reproductive parameters, but
nduced abortive effect in female treated with doses of 0.25 and
.5 g/kg/day of Cassia occidentalis, suggesting a toxic effect of Cas-
ia occidentalis stems and leaves during pregnancy (Aragão et al.,
009). Herein, we sought to evaluate the extension of the acute
nd subacute treatment with Cassia occidentalis stem and leaf in
emale and male Wistar rats.
. Materials and methods
.1. Plant material
The plant samples were collected (June, 2007) in the city of
imoeiro, state of Pernambuco, Brazil. A voucher specimen was
uthenticated in the Department of Botany of the Federal Univer-
ity of Pernambuco (UFPE) and was deposited at Geraldo Mariz
erbarium (number 45936).
.2. Extraction
The hydroalcoholic extract of Cassia occidentalis stems and
eaves used in the present study was supplied by Pharmaceutical
aboratory (LAPERLI, Recife, Brazil; lot number 003/2007). Extrac-
ion was performed by macerating air-dried, powdered Cassia
ccidentalis with 70% ethanol at room temperature for 7 days, and
as occasionally shaken. In the laboratory, the crude hydroalco-
olic extractwasﬁltered, concentratedunder reducedpressure and
yophilized (Tecnape, Technology in dehydration Ltda - Ribeirão
reto, Brazil) to yield approximately 17%. The dry residue was
tored at 4 ◦C, and, at the time of use, was resuspended in distilled
ater.
.3. Chromatographic analysis
Methods of Harbone (1984) and Wagner and Bladt (1996) were
sed to screen the Cassia occidentalis extract for the ﬂavonoids,
aponins, alkaloids, triterpenoids, iridoids and anthraquinone. The
hytochemical proﬁlewasdrawnupusing thin-layer chromatogra-
hy (TLC) in silica gel plates (Merck® art. 105553, UV 250–366nm)
sing the appropriate mobile phase, reagents and standards.
.4. Animals
Adult male and female Wistar rats (Rattus norvegicus var. albi-
us), aged 2 and 3 months, weighing 250–320g and 120–180g,
espectively, were obtained from Animal Care of the Department
f Physiology and Pharmacology at the Federal University of Per-
ambuco (UFPE), Brazil. The animals were maintained in standard
onditions (22–24◦ C; 12:12hdark/light cycle).Water and industri-
lized dry food (Labina®, Purina, Brazil) were available ad libitum.
he experimental protocols were approved by the Animal Exper-
mentation Ethics Committee of the Biological Science Center of
FPE (Process no. 23076.006893/2008-84) and are in accordance
ith the National Institute of Health Guidelines (USA) for the Care
nd Use of Laboratory Animals.
.5. Acute toxicity
Healthy Wistar rats were fasted overnight, but with free access
o water. Animals were randomly divided in ﬁve groups of male
nd ﬁve groups of female (n=5/group). The ﬁrst group (control
roup) received orally distilled water. Groups 2, 3, 4 and 5 were
rally treatedwithCassia occidentalis in doses of 0.625, 1.25, 2.5 andrmacology 136 (2011) 341–346
5.0 g/kg, respectively. Animals were observed for general behav-
ioral and bodyweight changes, hazardous symptoms andmortality
for a period of 14 days after treatment.
2.6. Subacute toxicity
This protocol was performed according to the Organization for
Economic Cooperation and Development (OECD) Test Guidelines
with slight modiﬁcations (OECD, 2007). Healthy male and female
rats were randomly divided into four groups by sex (n=10/group).
Animals received vehicle orally (water; control group) or Cas-
sia occidentalis in doses of 0.10, 0.50 or 2.5 g/kg/day for 30
consecutive days. Body weight was weekly recorded and food con-
sumption and water intake were daily monitored. Animals were
observed for signs of abnormalities during whole treatment. At
the end of the treatment, animals were fasted overnight, but with
water ad libitum. They were then anesthetized with pentobarbital
sodium 0.035g/kg (i.p.) (Nembutal®, Abbott Laboratories, Chicago,
IL), and blood samples were obtained by retro-orbital puncture
(Waynforth, 1980), using capillary tubes for hematological and
biochemical studies, with and without anticoagulant ethylenedi-
aminetetraacetic acid (EDTA), respectively.
2.7. Hematological and biochemical analysis
Hematological analysis was performed using an automatic
hematological analyzer (Coulter STKS, Beckman). Parameters
included: red blood cell (RBC) count, white blood cell (WBC) count,
hemoglobin (Hb), hematocrit (Hct), mean corpuscular volume
(MCV), mean corpuscular hemoglobin (MCH), mean corpuscu-
lar hemoglobin concentration (MCHC), red cell distribution width
(RDW), platelets count andmeanplatelet volume (MPV). Thediffer-
ential leukocyte count was performed with an optical microscopy
after staining and, in each case, 100 cells were counted. For bio-
chemical analysis, blood was centrifuged at 1500× g for 10min to
obtain serum,whichwas stored at−20 ◦C the following parameters
were determined: glucose; blood urea nitrogen (BUN); creatinine;
aspartate aminotransferase (AST); alanine aminotransferase (ALT);
total cholesterol; triglycerides; alkaline phosphatase (ALP); total
protein; albumin; total and direct bilirubin; chloride; potassium
and sodium. Dosages were made using Architect (Abott®) automa-
tionwithBoehringer Ingelheim® biochemical kits (Silvaet al., 2007;
Costa-Silva et al., 2008).
2.8. Morphological study
Macroscopic and microscopic features of the organs of male
and female rats were compared in the control and 2.5 g/kg
treated groups. After the animals were euthanized with an
excess of Nembutal® (0.140g/kg, i.p.), necropsy was performed
(n=5/group/sex) to analyze the macroscopic external features
of the heart, liver, spleen, lungs, kidney, adrenal gland, esopha-
gus, stomach, small intestine (fragment of 6–7 cm), hypophysis,
hypothalamus, brain and reproductive organs (uterus and ovary
or testicle, prostate, epididymis, seminal vesicle and vas deferens).
These organs were carefully removed and weighed individually.
Organ weights were expressed in absolute and relative terms (g
and g/100g of bodyweight, respectively). Histological examination
was performed in ﬁve animals per group/sex, randomly selected in
the group. Animalswere anesthetizedwithNembutal® (0.035g/kg,
i.p.), perfused with saline solution (for removal of blood) followed
by buffered formalin solution (10%) for 10min and the same organs
were removed and ﬁxed in Bouin solution for 48h at room tem-
perature. Tissue slices were processed according to the method
described by Lison (1960) and stained with hematoxylin/eosin.



























































Fig. 1. Bodyweightgain curvesofmale rats treatedorallywith theCassia occidentalis
extract (CO–0.10, 0.50 and2.5 g/kg) byoral route for 30 consecutivedays. Thevalues
are expressed as mean± SEM (n=10 animals/group).
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.9. Statistical analysis
Values are expressed as mean value± standard error of mean
SEM). Variance in data for body weights, food and water con-
umption, hematology, serum biochemistry and organ weights
both absolute and relative weights) was checked for homogene-
ty by Bartlett’s procedure. If the variance was homogeneous, the
ata were assessed by one-way analysis of variance (ANOVA) fol-
owed by the Tukey test. If not, the Kruskal–Wallis test was applied
nd when statistically signiﬁcant differences were indicated, the
unn test was employed for comparison between the control
nd treatment groups. A probability level lower than 5% (p<0.05)
as considered signiﬁcant. Statistical analyses were performed in
raphPad Prism 5 software®.
. Results
.1. Chromatographic analysis
The results obtained by TLC showed the presence of ﬂavonoids,
nthraquinones, triterpenes, small amount of saponins and the
bsence of iridoids and alkaloids in the hydroalcoholic extract of
assia occidentalis stem and leaf.
.2. Acute toxicity
No deaths or hazardous signs were recorded in rats during 14
ays of observation after acute treatment by oral route with Cassia
ccidentalis in doses of 0.625, 1.25, 2.5 and 5.0 g/kg.
.3. Subacute toxicity
No toxicity signs (such as piloerection, alteration in the loco-
otor activity or food and water consumption) or deaths were
ecorded during the 30 consecutive days of treatment by oral route
ith Cassia occidentalis in doses of 0.10, 0.50 and 2.5 g/kg. Likewise,
o signiﬁcant changes were recorded in body weight gain of con-
rol and treated rats (Figs. 1 and 2). However, the rats treated with
assia occidentalis (0.10, 0.50 and 2.5 g/kg) presented a mild diar-
hea during the period of treatment, suggesting a laxative effect of
he hydroalcoholic extract.
The treatment with hydroalcoholic extract of Cassia occidentalis
or 30 days (0.10, 0.50 and 2.5 g/kg) did not change the biochemical
roﬁle of male and female rats, as shown in Tables 1 and 2, respec-
ively. In the same way, the hematological proﬁle of male (Table 3)
nd female rats (Table 4) was not altered by treatment with Cassia
ccidentalis. In both biochemical and hematological studies, all val-
able 1
ffects of Cassia occidentalis extract (CO – 0.10, 0.50 and 2.5 g/kg) by oral route on biochem
Parameter Control CO 0.1
Glucose (mg/dL) 70.19 ± 4.31 74.26
BUN (mg/dL) 38.37 ± 3.37 42.85
Creatinine (mg/dL) 0.57 ± 0.02 0.61
AST (U/L) 133.90 ± 6.00 146.40
ALT (U/L) 46.40 ± 4.41 47.50
Total cholesterol (mg/dL) 65.85 ± 3.63 61.33
Triglycerides (mg/dL) 81.72 ± 5.73 70.59
Alkaline phosphatase (U/L) 141.40 ± 13.66 171.70
Total bilirrubin (mg/dL) 0.70 ± 0.01 0.80
Direct bilirrubin (mg/dL) 0.30 ± 0.01 0.40
Total protein (g/dL) 6.96 ± 0.11 6.90
Albumin (g/dL) 4.05 ± 0.07 4.18
Chlorine (mequiv./L) 108.53 ± 3.92 105.12
Potassium (mequiv./L) 4.91 ± 0.06 4.91
Sodium (mequiv./L) 144.16 ± 0.28 144.78
alues represent the mean± SEM (n=10/group). BUN, blood urea nitrogen; AST, aspartatFig. 2. Body weight gain curves of female rats treated orally with the Cassia occi-
dentalis extract (CO – 0.10, 0.50 and 2.5 g/kg) by oral route for 30 consecutive days.
The values are expressed as mean± SEM (n=10 animals/group).
ues in control and treated groups were within the reference range
for the species (Harkness and Wagner, 1993).
3.4. Morphological analysisThe absolute and relative tissue weights were not altered by
Cassia occidentalis treatment (Tables 5 and 6). The macroscopic
analysis of the target organs of the treated animals did not show
ical parameters in male Wistar rats treated for 30 consecutive days.
0 g/kg CO 0.50g/kg CO 2.5 g/kg
± 1.29 73.05 ± 3.11 70.96 ± 2.84
± 2.09 37.66 ± 1.38 39.13 ± 2.70
± 0.02 0.59 ± 0.01 0.60 ± 0.00
± 6.37 146.60 ± 6.08 152.90 ± 8.88
± 1.18 49.10 ± 3.87 51.33 ± 3.30
± 3.65 56.46 ± 3.87 61.35 ± 4.40
± 6.46 85.50 ± 6.44 92.63 ± 14.29
± 14.49 156.40 ± 16.73 143.20 ± 6.64
± 0.01 0.80 ± 0.01 0.70 ± 0.01
± 0.01 0.50 ± 0.01 0.30 ± 0.01
± 0.09 6.80 ± 0.10 7.03 ± 0.06
± 0.04 4.15 ± 0.06 4.17 ± 0.07
± 0.41 106.43 ± 1.08 106.73 ± 0.55
± 0.07 4.85 ± 0.10 4.97 ± 0.07
± 0.45 145.94 ± 0.42 145.83 ± 0.65
e aminotransferase; ALT, alanine aminotransferase.
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Table 2
Effects of Cassia occidentalis extract (CO – 0.10, 0.50 and 2.5 g/kg) by oral route on biochemical parameters in female Wistar rats treated for 30 consecutive days.
Parameter Control CO 0.10g/kg CO 0.50g/kg CO 2.5 g/kg
Glucose (mg/dL) 86.70 ± 5.49 79.16 ± 4.90 75.73 ± 5.21 89.25 ± 4.41
BUN (mg/dL) 43.10 ± 1.43 39.43 ± 1.10 38.42 ± 2.18 41.01 ± 1.28
Creatinine (mg/dL) 0.64 ± 0.02 0.59 ± 0.01 0.60 ± 0.02 0.62 ± 0.01
AST (U/L) 119.10 ± 5.76 132.90 ± 9.36 114.56 ± 6.10 118.80 ± 5.93
ALT (U/L) 49.90 ± 2.39 46.80 ± 0.92 52.56 ± 5.53 50.50 ± 2.16
Total cholesterol (mg/dL) 93.09 ± 3.94 83.46 ± 6.10 88.70 ± 6.19 90.73 ± 5.04
Triglycerides (mg/dL) 54.84 ± 8.00 49.56 ± 8.72 56.53 ± 4.86 58.49 ± 8.84
Alkaline phosphatase (U/L) 115.40 ± 3.64 124.60 ± 7.16 144.44 ± 9.97 136.60 ± 10.69
Total bilirrubin (mg/dL) 0.70 ± 0.01 0.70 ± 0.01 0.80 ± 0.01 0.70 ± 0.01
Direct bilirrubin (mg/dL) 0.20 ± 0.01 0.30 ± 0.01 0.50 ± 0.01 0.30 ± 0.01
Total protein (g/dL) 6.96 ± 0.08 6.85 ± 0.16 7.11 ± 0.19 6.74 ± 0.11
Albumin (g/dL) 4.40 ± 0.07 4.19 ± 0.11 4.53 ± 0.09 4.42 ± 0.05
Chlorine (mequiv./L) 103.68 ± 0.80 100.44 ± 1.69 104.79 ± 0.51 103.89 ± 0.36
Potassium (mequiv./L) 4.65 ± 0.14 4.31 ± 0.13 4.23 ± 0.10 4.53 ± 0.12
Sodium (mequiv./L) 142.38 ± 0.42 139.07 ± 1.98 142.37 ± 0.42 142.36 ± 0.38
Values represent the mean± SEM (n=10/group). BUN, blood urea nitrogen; AST, aspartate aminotransferase; ALT, alanine aminotransferase.
Table 3
Effects of Cassia occidentalis extract (CO – 0.10, 0.50 and 2.5 g/kg) by oral route on hematological parameters in male Wistar rats treated for 30 consecutive days.
Parameter Control CO 0.10g/kg CO 0.50g/kg CO 2.5 g/kg
Erythrocytes (106/L) 7.87 ± 0.10 8.11 ± 0.06 8.14 ± 0.03 8.05 ± 0.09
Hemoglobin (g/dL) 14.25 ± 0.20 14.79 ± 0.22 14.54 ± 0.07 14.62 ± 0.12
Hematocrit (%) 40.31 ± 0.56 41.91 ± 0.48 41.79 ± 0.54 42.12 ± 0.35
MCV (fL) 51.17 ± 0.42 51.65 ± 0.44 50.46 ± 0.52 51.64 ± 0.65
MCH (pg) 18.13 ± 0.29 18.17 ± 0.17 17.83 ± 0.15 18.09 ± 0.25
MCHC (g/dL) 35.37 ± 0.36 35.15 ± 0.09 35.29 ± 0.14 34.96 ± 0.12
RDW (%) 19.15 ± 2.68 14.75 ± 0.33 16.82 ± 1.77 16.99 ± 2.33
Platelets (103/L) 1067.80 ± 36.08 987.00 ± 35.52 937.30 ± 39.02 1010.50 ± 32.53
MPV (fL) 5.07 ± 0.06 5.33 ± 0.05 5.34 ± 0.11 5.13 ± 0.06
WBC (103/L) 9.20 ± 0.99 10.37 ± 0.78 9.80 ± 1.35 10.58 ± 0.47
Neutrophils (%) 31.20 ± 3.46 39.30 ± 2.09 41.20 ± 2.68 33.50 ± 2.91
Eosinophils (%) 1.00 ± 0.01 1.60 ± 0.24 1.75 ± 0.48 2.40 ± 0.51
Lymphocytes (%) 67.40 ± 3.41 58.60 ± 2.16 56.70 ± 2.77 63.50 ± 3.14
Monocytes (%) 1.22 ± 0.15 1.30 ± 0.15 1.40 ± 0.22 2.00 ± 0.44
Values represent the mean± SEM (n=10/group). MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration;
RDW, red cell distribution width; WBC, white blood cell; MPV, mean platelet volume.
Table 4
Effects of Cassia occidentalis extract (CO – 0.10, 0.50 and 2.5 g/kg) by oral route on hematological parameters in female Wistar rats treated for 30 consecutive days.
Parameter Control CO 0.10g/kg CO 0.50g/kg CO 2.5 g/kg
Erythrocytes (106/L) 7.64 ± 0.12 7.46 ± 0.14 7.51 ± 0.09 7.61 ± 0.09
Hemoglobin (g/dL) 14.95 ± 0.18 14.74 ± 0.11 14.29 ± 0.12 14.47 ± 0.12
Hematocrit (%) 42.69 ± 0.58 41.73 ± 0.90 40.96 ± 0.41 41.13 ± 0.40
MCV (fL) 55.82 ± 0.39 55.83 ± 0.45 54.47 ± 0.29 53.98 ± 0.28
MCH (pg) 19.57 ± 0.15 19.80 ± 0.39 19.02 ± 0.11 19.01 ± 0.11
MCHC (g/dL) 35.03 ± 0.10 35.47 ± 0.82 34.86 ± 0.13 35.17 ± 0.07
RDW (%) 11.31 ± 0.06 11.35 ± 0.22 11.48 ± 0.18 11.99 ± 0.20
Platelets (103/L) 1073.20 ± 42.81 1020.80 ± 24.67 986.10 ± 34.89 1105.70 ± 29.04
MPV (fL) 5.19 ± 0.07 5.38 ± 0.06 5.33 ± 0.06 5.18 ± 0.05
WBC (103/L) 10.90 ± 1.23 8.41 ± 0.33 7.85 ± 0.62 9.04 ± 1.03
Neutrophils (%) 17.60 ± 3.21 22.70 ± 1.25 25.10 ± 3.16 25.80 ± 7.79
Eosinophils (%) 1.25 ± 0.25 1.40 ± 0.24 1.25 ± 0.25 1.67 ± 0.67
Lymphocytes (%) 79.00 ± 3.61 74.80 ± 1.42 73.20 ± 3.19 71.70 ± 7.68










aalues represent the mean± SEM (n=10/group). MCV, mean corpuscular volume; M
DW, red cell distribution width; WBC, white blood cell; MPV, mean platelet volum
igniﬁcant changes in color and texture when compared with the
ontrol group. In addition, the microscopical analysis did not show
istological alterations in all organs examined (data not shown).
. Discussion
Medicinal plants and their derivates have been used as an
lternative to allopathic medicines in many countries. Despite the
idespread use, few scientiﬁc studies have been undertaken to
scertain the safety and efﬁcacy of traditional remedies (Grac¸a et
l., 2007). Cassia occidentalis, found in many tropical areas aroundean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration;
the world, has been used as a medicinal plant for hundreds of
years (Di Stasi and Hiruma-Lima, 2002). In Brazil, the species is
cultivated and commercialized with anti-inﬂammatory, laxative,
analgesic, febrifuge and diuretic. Considering the large medicinal
use of Cassia occidentalis worldwide, our laboratory has evaluated
its toxicity. In folk medicine, leaf infusion of Cassia occidentalis
is commonly used as purgative, febrifuge and diuretic, one cup
daily (approximately 125mg/kg/day; Balbach, 1986). In relation to
the herbal product Cassia Virgínica® (LAPERLI, Recife, Brazil), the
recommended dosage for ﬂu and fever is 25mg/kg/day. Thus, in
the present study, we used doses of 4 times (0.10g/kg), 20 times
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Table 5
Effects of Cassia occidentalis extract (CO – 2.5 g/kg) by oral route on absolute (g)
and relative (g/100g of animal) organ weight in male Wistar rats treated for 30
consecutive days.
Parameter Control CO 2.5 g/kg
Spleen (g) 0.69 ± 0.05 0.58 ± 0.06
(g/100g) 0.177 ± 0.010 0.159 ± 0.004
Brain (g) 1.31 ± 0.05 1.03 ± 0.10
(g/100g) 0.338 ± 0.011 0.277 ± 0.075
Heart (g) 1.34 ± 0.04 1.45 ± 0.13
(g/100g) 0.346 ± 0.011 0.382 ± 0.001
Vas deferens (g) 0.11 ± 0.01 0.11 ± 0.00
(g/100g) 0.027 ± 0.002 0.031 ± 0.003
Epididymis (g) 0.56 ± 0.01 0.51 ± 0.06
(g/100g) 0.146 ± 0.003 0.126 ± 0.015
Esophagus (g) 0.10 ± 0.01 0.12 ± 0.02
(g/100g) 0.025 ± 0.003 0.033 ± 0.005
Stomach (g) 1.85 ± 0.16 1.74 ± 0.17
(g/100g) 0.473 ± 0.026 0.483 ± 0.018
Liver (g) 13.00 ± 0.56 12.01 ± 1.55
(g/100g) 3.343 ± 0.067 3.301 ± 0.058
Adrenal gland (g) 0.02 ± 0.00 0.02 ± 0.00
(g/100g) 0.005 ± 0.0004 0.006 ± 0.0004
Hypophysis (g) 0.01 ± 0.00 0.01 ± 0.00
(g/100g) 0.001 ± 0.0003 0.002 ± 0.0006
Hypothalamus (g) 0.03 ± 0.01 0.25 ± 0.19
(g/100g) 0.011 ± 0.002 0.055 ± 0.039
Small intestine (g) 0.28 ± 0.05 0.41 ± 0.02
(g/100g) 0.128 ± 0.010 0.111 ± 0.014
Prostate (g) 0.52 ± 0.06 0.47 ± 0.04
(g/100g) 0.095 ± 0.027 0.134 ± 0.014
Lungs (g) 1.98 ± 0.05 1.95 ± 0.05
(g/100g) 0.509 ± 0.007 0.554 ± 0.044
Kidney (g) 1.44 ± 0.08 1.32 ± 0.14
(g/100g) 0.370 ± 0.010 0.365 ± 0.008
Testicle (g) 1.68 ± 0.09 1.48 ± 0.08
(g/100g) 0.432 ± 0.018 0.418 ± 0.035
Seminal vesicle (g) 0.91 ± 0.14 0.85 ± 0.18
(g/100g) 0.236 ± 0.040 0.228 ± 0.021
Values represent the mean± SEM (n=5/group).
Table 6
Effects of Cassia occidentalis extract (CO – 2.5 g/kg) by oral route on absolute (g)
and relative (g/100g of animal) organ weight in female Wistar rats treated for 30
consecutive days.
Parameter Control CO 2.5 g/kg
Spleen (g) 0.47 ± 0.05 0.42 ± 0.03
(g/100g) 0.204 ± 0.016 0.211 ± 0.013
Brain (g) 1.13 ± 0.05 1.04 ± 0.05
(g/100g) 0.500 ± 0.029 0.529 ± 0.036
Heart (g) 0.85 ± 0.06 0.92 ± 0.04
(g/100g) 0.376 ± 0.030 0.463 ± 0.018
Esophagus (g) 0.09 ± 0.003 0.09 ± 0.001
(g/100g) 0.039 ± 0.002 0.043 ± 0.001
Stomach (g) 1.32 ± 0.04 1.22 ± 0.02
(g/100g) 0.594 ± 0.018 0.616 ± 0.006
Liver (g) 8.22 ± 0.18 7.79 ± 0.44
(g/100g) 3.610 ± 0.077 3.930 ± 0.156
Adrenal gland (g) 0.02 ± 0.002 0.02 ± 0.003
(g/100g) 0.010 ± 0.001 0.008 ± 0.004
Hypophysis (g) 0.004 ± 0.0002 0.005 ± 0.001
(g/100g) 0.002 ± 0.0001 0.003 ± 0.001
Hypothalamus (g) 0.03 ± 0.001 0.03 ± 0.002
(g/100g) 0.012 ± 0.0003 0.013 ± 0.001
Small intestine (g) 0.51 ± 0.02 0.46 ± 0.05
(g/100g) 0.222 ± 0.009 0.235 ± 0.029
Ovary (g) 0.043 ± 0.003 0.045 ± 0.001
(g/100g) 0.019 ± 0.002 0.023 ± 0.001
Lungs (g) 1.09 ± 0.03 1.27 ± 0.05
(g/100g) 0.479 ± 0.017 0.642 ± 0.028
Kidney (g) 0.83 ± 0.03 0.83 ± 0.02
(g/100g) 0.365 ± 0.019 0.418 ± 0.010
Uterus (g) 0.55 ± 0.09 0.36 ± 0.01
(g/100g) 0.242 ± 0.042 0.182 ± 0.004
Values represent the mean± SEM (n=5/group).rmacology 136 (2011) 341–346 345
(0.50 g/kg) and 100 times (2.5 g/kg) higher than that recommended
for therapeutic properties.
Despite toxicological studieshave shownthepotent toxic effects
of Cassia occidentalis seeds (O’Hara et al., 1969; Calore et al., 1997;
Tasaka et al., 2000; Haraguchi et al., 2003), the present study
showed that Cassia occidentalis stems and leaves in acute dose by
oral route (up to 5.0 g/kg) did not produce any sign of toxicity or
death in rats, suggesting a letal dose 50% (LD50) above 5.0 g/kg.
According to Kennedy et al. (1986), substances that present LD50
higher than 5.0 g/kg by oral route may be considered practically
non-toxic, suggesting that acute toxicity of the Cassia occidentalis
stem and leaf is practically null.
Previous studies from our laboratory demonstrated that oral
treatment of pregnant rats with hydroalcoholic extract of Cas-
sia occidentalis stem and leaf in doses of 0.25 and 0.5 g/kg did
not change the most of reproductive parameters. However, it was
observed the presence of dead fetuses from pregnant rats treated
with Cassia occidentalis 0.25 and 0.5 g/kg, suggesting a possible
abortive effect of this extract (Aragão et al., 2009). Herein, oral
administration of Cassia occidentalis in male and female rats for
30 days in doses of 0.10, 0.50 and 2.5 g/kg/day failed to pro-
duce signs of toxicity, such as general behavioral and body weight
changes, hazardous symptoms and mortality. However, diarrhea
was observed in rats during whole period of treatment with Cassia
occidentalis. This laxative effect is characteristic in Cassia species as
described by Elujoba et al. (1999). Anthraquinone derivates have
been identiﬁed as the chemical constituents of the Cassia species
responsible for laxative and purgative activities (Akomolafe et al.,
2003). Cassia occidentalis has small amounts of anthraquinone and
has demonstrated only a mild laxative effect in rats (Elujoba et al.,
1989), as that observed in the present study. According Haraguchi
et al. (1996, 2003) anthraquinones were considered the secondary
metabolites responsible for toxic effects, such as ataxia, muscle
weakness, stubbing, body weight loss and death induced by oral
intake of Cassia occidentalis seeds in rats. Haraguchi et al. (1996)
showed that part of these toxic effects were due to presence of
dianthrone, an antharquinone-derived compound. In our study,we
did not observe these kinds of toxic effects, suggesting that the
hydroalcoholic extract of Cassia occidentalis stem and leaf may not
have the dianthrone. The low amount of anthraquinones observed
by chromatography analysis of Cassia occidentalis stem and leaf
corroborate with this hypothesis (Elujoba et al., 1989).
In the present study, all hematological and biochemical param-
eters remained under the reference range for the species (Harkness
and Wagner, 1993) and no statistical signiﬁcant changes were
observed between groups. Analysis of blood parameters is rele-
vant for risk evaluation, as any changes in the hematological and
biochemical systems have a higher predictive value for human tox-
icity, when data are translated from animal studies (Olson et al.,
2000). Since therewasno effect on the levels of transaminases (ALT,
AST) and creatinine, which are good indicators of liver and kidney
functions, respectively, it is reasonable to suggest that the Cassia
occidentalis extract did not induce any damage to the liver and the
kidneys. This is further conﬁrmed by the histological assessment
of these organs, and the fact that there was no effect on plasma
cholesterol levels, suggesting a normal function of the liver (Hilaly
et al., 2004). In the other hand, studies of Muyibi et al. (2000) eval-
uated the effects of the oral subacute treatment (42 days) with
aqueous extract of Cassia occidentalis leaf (1, 2 and 4g/kg) on mean
cell volume (MCV), hemoglobin concentration (HC), red and white
blood cell count (RBC andWBC, respectively) and observed statistic
reduction in the PCV, HC and RBC in the treated groups. However,
although MCV and HC values were lower than control group val-
ues, they were within the reference range for the specie and may
be considered physiologic values (Harkness and Wagner, 1993). In
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eaf 4 g/kg was below the reference values, indicating an anemia
n these animals. In the other hand, recent studies of Ibrahim et al.
2010) demonstrated that Cassia occidentalis leaf extract improves
he trypanosome-induced anemia. In the present study, no effect
as observed in the eritrocytes count of the treated groups, show-
ng that the subacute treatment with hydroalcoholic extract of
assia occidentalis stem and leaf (0.10, 0.50 and 2.5 g/kg) produced
o damage in the red blood cells.
Macroscopic and microscopic examination of organs from ani-
als treated with the highest dose and control animals showed
ormal architecture, suggesting no detrimental changes and mor-
hological disorder induced by oral administration of the Cassia
ccidentalis for 30 days. Since the oral dose of 2.5 g/kg/day of Cassia
ccidentalis administered for 30 consecutives days was the highest
ose used in subacute studies and that it did not induce any bio-
hemical, hematological, anatomical and histopathological signs of
oxicity, it can be deﬁned as the no-observed-adverse-effect level
NOAEL) for Wistar rats of both sexes under experimental condi-
ions used.
Taken together, our data suggested that the acute and subacute
ral administrations of hydroalcoholic extract of Cassia occidentalis
tems and leaves produced no signiﬁcative toxic effects in male
nd female Wistar rats, which could stand as an assurance for the
edicinal use of this plant in folk medicine.
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